Bluejay Therapeutics Announces Expansion of Leadership Team and Board of Directors


SAN MATEO, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Bluejay Therapeutics, a clinical-stage biopharmaceutical company rapidly progressing transformative therapies for viral hepatitis and other serious liver diseases, today announced the expansion of its leadership team and board of directors.

Continue reading here:
Bluejay Therapeutics Announces Expansion of Leadership Team and Board of Directors

Related Posts